Tip Sheet: Immunotherapy Trial Results for Cancer among Research Presentations by Johns Hopkins Scientists

Reading Time: 1 minutes

Combining two checkpoint inhibitors, drugs that remove inhibitory signals and restore the immune system’s ability to fight cancer, may be effective in shrinking melanoma tumors or preventing their growth in some patients who previously received standard therapy, according to new research results from the Johns Hopkins Bloomberg~Kimmel Institute. (ASCO Abstract 9520).

Leave a Reply

Your email address will not be published. Required fields are marked *